Lexicon Pharmaceuticals LXRX Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's share-based payment arrangement, decrease for tax withholding obligation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's share-based payment arrangement, decrease for tax withholding obligation?
- Lexicon Pharmaceuticals (LXRX) reported share-based payment arrangement, decrease for tax withholding obligation of $2.84M in Q1 2026.
- How has Lexicon Pharmaceuticals's share-based payment arrangement, decrease for tax withholding obligation changed year-over-year?
- Lexicon Pharmaceuticals's share-based payment arrangement, decrease for tax withholding obligation increased by 397.0% year-over-year, from $572K to $2.84M.
- What does share-based payment arrangement, decrease for tax withholding obligation mean?
- The cash outflow or reduction in equity resulting from the company settling tax withholding obligations on behalf of employees during share-based compensation vesting. It represents a recurring cash impact related to employee equity programs.